User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Search

Displaying 5 results.
    • Journal article
    Gene alterations in epigenetic modifiers and JAK-STAT signaling are frequent in breast implant-associated ALCL.
    Laurent, Camille Nicolae, Alina Laurent, Cécile Le Bras, Fabien Haioun, Corinne Fataccioli, Virginie Amara, Nadia Adélaïde, José Guille, Arnaud Schiano, Jean-Marc Tesson, Bruno Traverse-Glehen, Alexandra Chenard, Marie-Pierre Mescam, Lénaïg Moreau, Anne Chassagne-Clement, Catherine Somja, Joan Escudié, Fréderic André, Marc[UCL] Martin, Nadine Lacroix, Laetitia Lemonnier, François Hamy-Petit, Anne-Sophie Reyal, Fabien Bannier, Marie Oberic, Lucie Prade, Nais Frénois, François-Xavier Beldi-Ferchiou, Asma Delfau-Larue, Marie-Helene Bouabdallah, Reda Birnbaum, Daniel Brousset, Pierre Xerri, Luc Gaulard, Philippe (2020) Blood — Vol. 135, no. 5, p. 360-370 (2020)
    • Journal article
    BH3 profiling identifies ruxolitinib as a promising partner for venetoclax to treat T-cell prolymphocytic leukemia.
    Herbaux, Charles Kornauth, Christoph Poulain, Stéphanie Chong, Stephen J F Collins, Mary C Valentin, Rebecca Hackett, Liam Tournilhac, Olivier Lemonnier, François Dupuis, Jehan Daniel, Adrien Tomowiak, Cecile Laribi, Kamel Renaud, Loïc Roos-Weil, Damien Rossi, Cedric Van Den Neste, Eric[UCL] Leyronnas, Cecile Merabet, Fatiha Malfuson, Jean Valère Tiab, Mourad Ysebaert, Loïc Ng, Samuel Morschhauser, Franck Staber, Philipp B Davids, Matthew S (2021) Blood — Vol. 137, no.25, p. 3495-3506 (2021)
    • Journal article
    Rituximab plus gemcitabine and oxaliplatin (R-GemOx) in refractory/relapsed diffuse large B-cell lymphoma: a real-life study in patients ineligible for autologous stem-cell transplantation.
    Cazelles, Clarisse Belhadj, Karim Vellemans, Hélène[UCL] Camus, Vincent Poullot, Elsa Gaulard, Philippe Veresezan, Liana Itti, Emmanuel Becker, Stéphanie Carvalho, Muriel Dupuis, Jehan Le Bras, Fabien Lemonnier, François Roulin, Louise El Gnaoui, Taoufik Jardin, Fabrice Mounier, Nicolas Tilly, Hervé Haioun, Corinne (2021) Leukemia & lymphoma — Vol. 62, no. 9, p. 2161-2168 (2021)
    • Journal article
    Oral azacitidine compared with standard therapy in patients with relapsed or refractory follicular helper T-cell lymphoma (ORACLE): an open-label randomised, phase 3 study.
    Dupuis, Jehan Bachy, Emmanuel Morschhauser, Franck Cartron, Guillaume Fukuhara, Noriko Daguindau, Nicolas Casasnovas, René-Olivier Snauwaert, Sylvia Gressin, Remy Fox, Christopher P d'Amore, Francesco Annibale Staber, Philipp B Tournilhac, Olivier Bouabdallah, Krimo Thieblemont, Catherine André, Marc[UCL] Rai, Shinya Ennishi, Daisuke Gkasiamis, Argyrios Nishio, Mitsufumi Fornecker, Luc-Matthieu Delfau-Larue, Marie-Helene Sako, Nouhoum Mule, Sebastien de Leval, Laurence Gaulard, Philippe Tsukasaki, Kunihiro Lemonnier, François (2024) The Lancet. Haematology — Vol. 11, no.6, p. e406-e414 (2024)
    • Journal article
    Oxaliplatin before autologous transplantation in combination with high-dose cytarabine and rituximab provides longer disease control than cisplatin or carboplatin in patients with mantle-cell lymphoma: results from the LyMA prospective trial.
    Tessoulin, Benoit Chiron, David Thieblemont, Catherine Oberic, Lucie Bouadballah, Kamal Gyan, Emmanuel Damaj, Gandhi Ribrag, Vincent Gressin, Rémy Feugier, Pierre Casasnovas, Olivier Zerazhi, Hacène Lemonnier, François Maisonneuve, Hervé Joubert, Clementine Van Den Neste, Eric[UCL] Lamy, Thierry Tilly, Hervé Moreau, Anne Hermine, Olivier Le Gouill, Steven (2021) Bone marrow transplantation — Vol. 56, no. 7, p. 1700-1709 (2021)